Labcorp Holdings INC Form 4 insider transactions

A Form 4 filing reveals Labcorp's EVP, CIO & CTO Akinbolade Oyegunwa's recent stock transactions, including the acquisition and disposal of common stock and derivative securities.

Julia Wang, CFO of Labcorp Holdings Inc., reports the acquisition of stock options and restricted stock units.

Kathryn E. Wengel, a director of Labcorp Holdings Inc., reported the acquisition of 897 restricted stock units on February 11, 2025, vesting fully on February 11, 2026.

Director Paul Rothman reports acquisition of restricted stock units in Labcorp Holdings Inc.

Director Richelle P. Parham reports acquisition of restricted stock units in Labcorp Holdings Inc.

Director Peter M. Neupert acquired 897 Restricted Stock Units in Labcorp Holdings Inc., vesting fully on February 11, 2026.

Director Kong Garheng acquired 897 restricted stock units of Labcorp Holdings Inc. on February 11, 2025, which vest on February 11, 2026.

Dwight Gary Gilliland, a director of Labcorp Holdings Inc., acquired 897 restricted stock units on February 11, 2025, which vest fully on February 11, 2026.

Director Jeffrey A. Davis reports acquisition of 897 restricted stock units in Labcorp Holdings Inc.

Director Kerrii B. Anderson reports acquisition of 897 restricted stock units in Labcorp Holdings Inc.

Director Kirsten Marie Kliphouse reports acquisition of 897 restricted stock units in Labcorp Holdings Inc.

Glenn Eisenberg, an Executive Vice President at Labcorp Holdings Inc., reported the vesting of restricted stock units and subsequent tax withholding.

Lance Berberian, EVP at Labcorp, reports the vesting and subsequent tax withholding of restricted stock units.

Brian J. Caveney, an executive at Labcorp Holdings Inc., reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Megan D. Bailey, EVP, Pres, Central Labs & Intl at Labcorp Holdings Inc., reports transactions involving common stock and restricted stock units.

A Form 4 filing reveals Labcorp's EVP, CIO & CTO Akinbolade Oyegunwa's recent transactions involving restricted stock units and common stock.

EVP and Chief Marketing Officer of Labcorp Holdings, Amy B. Summy, reports transactions involving restricted stock units and common stock.

Mark S. Schroeder, EVP, Pres Diagnostics & COO of Labcorp Holdings Inc., reports transactions involving common stock and restricted stock units.

Peter J. Wilkinson, SVP and Chief Accounting Officer of Labcorp Holdings Inc., reports transactions involving restricted stock units and common stock.

Labcorp CEO Adam Schechter reports the vesting and subsequent tax withholding of restricted stock units.

Sandra van der Vaart, EVP and Chief Legal Officer of Labcorp Holdings Inc., reports the vesting and subsequent tax withholding of restricted stock units.

Anita Z. Graham, EVP, CHRO of Labcorp Holdings Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Julia Wang, CFO of Labcorp Holdings Inc., reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Director Kathryn E. Wengel reports the vesting of restricted stock units into Labcorp Holdings Inc. common stock.

Director Richelle P. Parham reports the vesting of restricted stock units into Labcorp Holdings Inc. common stock.

Director Peter M. Neupert reports the vesting of restricted stock units into Labcorp Holdings Inc. common stock.

Director Kong Garheng reports the vesting of restricted stock units into Labcorp Holdings Inc. common stock.

Director Jeffrey A. Davis reports vesting of restricted stock units into Labcorp Holdings Inc. common stock.

Director Kirsten Kliphouse reported the vesting of restricted stock units and subsequent disposal of shares on February 6, 2025.

Director Kerrii B. Anderson reports vesting of restricted stock units into Labcorp Holdings Inc. common stock.